T 0873/21 (Combination treatment in equine animals / BOEHRINGER INGELHEIM VETMEDICA) of 20.06.2023
- European Case Law Identifier
- ECLI:EP:BA:2023:T087321.20230620
- Date of decision
- 20 June 2023
- Case number
- T 0873/21
- Petition for review of
- -
- Application number
- 15774881.5
- IPC class
- A61K 31/4045A61K 31/48A61K 31/428A61K 31/7042A61P 3/10A61K 9/00A61K 31/7056A61P 1/16A61P 43/00A61K 31/70A61K 31/506A61K 31/7048A61K 31/7034A61P 1/14A61P 9/12
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- Abstract on EPC2000 Art 056
- Application title
- COMBINATION TREATMENT OF SGLT2 INHIBITORS AND DOPAMINE AGONISTS FOR PREVENTING METABOLIC DISORDERS IN EQUINE ANIMALS
- Applicant name
- Boehringer Ingelheim Vetmedica GmbH
- Opponent name
- -
- Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56
- Keywords
- Inventive step - (yes)
- Catchword
- -
- Cited cases
- G 0002/21
- Citing cases
- T 0116/18
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the examining division with the order to grant a patent on the basis of the set of claims of the main request filed as auxiliary request 1 on 26 November 2020 and a description to be adapted thereto.